Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan in Acute Anterior MI After PCI
NCT04970238Phase 4Unknown
- Start
- Oct 2021
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute anterior myocardial infarction (AWMI) comparing Levosimendan group with Placebo group (2 arms). Primary endpoints: Occurrence of heart failure at 6 months, Major Adverse Cardiovascular Events at 6 months and 1 more. Status: unknown.
02
Drugs
levosimendan
03
Conditions
acute anterior myocardial infarction (AWMI)
Beyond the preview
Go deeper on NCT04970238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04970238.